Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
13
Bearish filings
24
Named actors
11
Disclosed $ (bull / bear)
$557K + 2 of unknown size / $11.3M + 3 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-14 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT BALL | filed notice to sell | $188K | SEC ↗ |
| 2026-09-14 | CEO & Executive Chairman Ball Robert Joseph | sold | $188K | SEC ↗ |
| 2026-09-14 | CEO & Executive Chairman Ball Robert Joseph | exercised options & held the shares | $166K | SEC ↗ |
| 2026-08-26 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $27K | SEC ↗ |
| 2026-08-24 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $15K | SEC ↗ |
12 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-21 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $464K | SEC ↗ |
| 2026-08-20 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $88K | SEC ↗ |
| 2026-08-18 | Chief Operating Officer Ahearn Matthew Fraser | sold | $263K | SEC ↗ |
| 2026-08-18 | Chief Operating Officer Ahearn Matthew Fraser | sold | $34K | SEC ↗ |
| 2026-08-17 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MATTHEW AHEARN | filed notice to sell | $466K | SEC ↗ |
| 2026-08-17 | Chief Operating Officer Ahearn Matthew Fraser | sold | $167K | SEC ↗ |
| 2026-08-14 | Chief Operating Officer Ahearn Matthew Fraser | gifted | — | SEC ↗ |
| 2026-08-07 | Activist (13D) — reduced stake Gilde Healthcare Holding B.V. | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-06 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $47K | SEC ↗ |
| 2026-08-05 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $166K | SEC ↗ |
| 2026-08-04 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $2.3M | SEC ↗ |
| 2026-08-03 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $244K | SEC ↗ |
| 2026-07-31 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $455K | SEC ↗ |
| 2026-07-30 | 10% owner / other Gilde Healthcare Holding B.V. | sold | $660K | SEC ↗ |
| 2026-07-29 | 10% Stockholder (via Van Lanschot Kempen N.V.) Gilde Healthcare Holding B.V.; Cooperatieve Gilde Healthcare V U.A. | filed notice to sell | $4.8M | SEC ↗ |
| 2026-06-15 | Chief Operating Officer Ahearn Matthew Fraser | sold | $30K | SEC ↗ |
| 2026-06-15 | Chief Operating Officer Ahearn Matthew Fraser | sold | $48K | SEC ↗ |
| 2026-06-12 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MATTHEW AHEARN | filed notice to sell | $375K | SEC ↗ |
| 2026-06-12 | Chief Operating Officer Ahearn Matthew Fraser | sold | $296K | SEC ↗ |
| 2026-05-13 | Chief Operating Officer Matthew Ahearn | adopted a selling plan | — | SEC ↗ |